147 related articles for article (PubMed ID: 17307058)
1. Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.
Uwaifo GI; Ratner RE
Am J Cardiol; 2007 Feb; 99(4A):51B-67B. PubMed ID: 17307058
[TBL] [Abstract][Full Text] [Related]
2. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
3. Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
Chaudhuri A; Dandona P
Diabetes Obes Metab; 2011 Oct; 13(10):869-79. PubMed ID: 21569185
[TBL] [Abstract][Full Text] [Related]
4. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
[No Abstract] [Full Text] [Related]
5. Role of oral anti-diabetic agents in modifying cardiovascular risk factors.
Shin JJ; Rothman J; Farag A; McFarlane SI; Sowers JR
Minerva Med; 2003 Dec; 94(6):401-8. PubMed ID: 14976468
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacologic treatment of diabetes].
De Montigny P; Clerc C; Descarpentries C
Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
[No Abstract] [Full Text] [Related]
7. [Clinically important effects of oral antidiabetic drug interactions].
Drzewoski J; Kopff B
Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985
[TBL] [Abstract][Full Text] [Related]
8. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Malesker MA
Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
[TBL] [Abstract][Full Text] [Related]
9. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B; Lund SS; Vaag A
Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral hypoglycemic agents on platelet function.
Papazafiropoulou A; Papanas N; Pappas S; Maltezos E; Mikhailidis DP
J Diabetes Complications; 2015 Aug; 29(6):846-51. PubMed ID: 26026848
[TBL] [Abstract][Full Text] [Related]
11. Effect of pioglitazone on the drivers of cardiovascular risk in type 2 diabetes.
Donnelly R
Int J Clin Pract; 2007 Jul; 61(7):1160-9. PubMed ID: 17511791
[TBL] [Abstract][Full Text] [Related]
12. Oral hypoglycemic agents and heart.
Manoria P; Manoria P
Indian Heart J; 2007; 59(3):266-72. PubMed ID: 19124937
[No Abstract] [Full Text] [Related]
13. Diabetes medications and body weight.
Mitri J; Hamdy O
Expert Opin Drug Saf; 2009 Sep; 8(5):573-84. PubMed ID: 19538102
[TBL] [Abstract][Full Text] [Related]
14. New oral agents for type II diabetes. Taking a more aggressive approach to therapy.
Hollander PA
Postgrad Med; 1995 Dec; 98(6):110-1, 115-6, 119-21, passim. PubMed ID: 7501573
[TBL] [Abstract][Full Text] [Related]
15. [Update on new oral treatment for diabetes].
Awad J; Schindel B; Schindel Y
Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
[No Abstract] [Full Text] [Related]
16. [Cardiovascular effects of oral hypoglycemie drugs].
Herrmann BL; Erbel R; Janssen OE; Mann K
Herz; 2004 Aug; 29(5):510-8. PubMed ID: 15340737
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and cardiometabolic protection: role of glitazones.
Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C
J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of thiazolidinediones.
Rizos CV; Liberopoulos EN; Mikhailidis DP; Elisaf MS
Expert Opin Pharmacother; 2008 May; 9(7):1087-108. PubMed ID: 18422468
[TBL] [Abstract][Full Text] [Related]
19. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
Wilcox R; Kupfer S; Erdmann E;
Am Heart J; 2008 Apr; 155(4):712-7. PubMed ID: 18371481
[TBL] [Abstract][Full Text] [Related]
20. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
Mazzone T
Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]